Medipharm Labs Corp (LABS) - Total Liabilities

Latest as of March 2026: CA$8.52 Million CAD ≈ $6.16 Million USD

Based on the latest financial reports, Medipharm Labs Corp (LABS) has total liabilities worth CA$8.52 Million CAD (≈ $6.16 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore LABS year-over-year net asset growth to track the company's year-over-year net asset growth rate.

Medipharm Labs Corp - Total Liabilities Trend (2016–2025)

This chart illustrates how Medipharm Labs Corp's total liabilities have evolved over time, based on quarterly financial data. See LABS FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Medipharm Labs Corp Competitors by Total Liabilities

The table below lists competitors of Medipharm Labs Corp ranked by their total liabilities.

Company	Country	Total Liabilities
Carnavale Resources Ltd AU:CAV	Australia	AU$242.97K
Country Club Hospitality & Holidays Limited NSE:CCHHL	India	Rs2.58 Billion
Egeplast Ege Plastik Ticaret ve Sanayi AS IS:EPLAS	Turkey	TL921.98 Million
Flagship Investments Ltd AU:FSI	Australia	AU$21.28 Million
ODTech Co. Ltd KQ:080520	Korea	₩7.53 Billion
enX Group Ltd JSE:ENX	South Africa	ZAC604.02 Million
Sebang Co Ltd KO:004365	Korea	₩292.28 Billion
Global Uranium and Enrichment Ltd AU:GUE	Australia	AU$11.73 Million

Liability Composition Analysis (2016–2025)

This chart breaks down Medipharm Labs Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Medipharm Labs Corp (LABS) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.02	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.24	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.20	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Medipharm Labs Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Medipharm Labs Corp (2016–2025)

The table below shows the annual total liabilities of Medipharm Labs Corp from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	CA$9.93 Million ≈ $7.18 Million	-5.88%
2024-12-31	CA$10.55 Million ≈ $7.63 Million	-3.53%
2023-12-31	CA$10.93 Million ≈ $7.91 Million	+15.19%
2022-12-31	CA$9.49 Million ≈ $6.86 Million	+2.98%
2021-12-31	CA$9.21 Million ≈ $6.67 Million	-76.86%
2020-12-31	CA$39.82 Million ≈ $28.80 Million	+5.89%
2019-12-31	CA$37.60 Million ≈ $27.20 Million	+152.61%
2018-12-31	CA$14.89 Million ≈ $10.77 Million	+489.78%
2017-12-31	CA$2.52 Million ≈ $1.83 Million	+5301.70%
2016-12-31	CA$46.73K ≈ $33.80K	--

About Medipharm Labs Corp

TO:LABS Canada Drug Manufacturers - Specialty & Generic

Market Cap

$23.05 Million

CA$31.86 Million CAD

Market Cap Rank

#24608 Global

#941 in Canada

Share Price

CA$0.08

Change (1 day)

+0.00%

52-Week Range

CA$0.06 - CA$0.09

All Time High

CA$7.17